Clinical and research tests for C1708353 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 41

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
HVA/VMA University of Minnesota Physicians Outreach Labs University of Minnesota Medical Center United States	1	1	A Analyte
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States	97	77	C Sequence analysis of the entire coding region
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States	71	54	C Sequence analysis of the entire coding region
Hereditary Cancer Screening - Breast Cancer Panel (19 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	22	19	X Mutation scanning of select exons
Hereditary Cancer Screening - Colorectal & Gastric Cancer Panel (including Pancreatic Cancer) - (43 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	58	43	X Mutation scanning of select exons
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	47	41	X Mutation scanning of select exons
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	52	44	X Mutation scanning of select exons
Hereditary Cancer Screening - Renal/Urinary Tract Cancer Panel (Including prostate and kidney cancer) - (39 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	40	39	X Mutation scanning of select exons
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	37	33	X Mutation scanning of select exons
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	109	99	X Mutation scanning of select exons
myRisk Hereditary Cancer Myriad Genetics, Inc. United States	32	46	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Pheochromocytoma and Paraganglioma Panel Genetic Services Laboratory University of Chicago United States	10	16	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Paraganglioma-Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States	12	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Paraganglioma-Pheochromocytoma (SDHA, SDHB, SDHC, and SDHD) Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States	1	4	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Endocrine Cancer Panel (12 Genes) Quest Diagnostics Nichols Institute San Juan Capistrano United States	6	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Comprehensive Hereditary Cancer Panel (66 Genes) Quest Diagnostics Nichols Institute San Juan Capistrano United States	35	66	D Deletion/duplication analysis C Sequence analysis of the entire coding region
OncoGeneDx Custom Panel GeneDx United States	103	82	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Paraganglioma-Pheochromocytoma Syndromes: gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	1	4	C Sequence analysis of the entire coding region
Hereditary Thyroid Cancer Panel Genetic Services Laboratory University of Chicago United States	11	13	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Paraganglioma-Pheochromocytoma Panel Blueprint Genetics Finland	1	11	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 41

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.